Extending beyond fetal safety, in a cohort of nearly 4,300 women who received GLP-1RA therapy within two years prior to conception, exposure was associated with a lower risk of developing gestational diabetes mellitus and hypertensive disorders of pregnancy 14
Photograph every vial upon arrival, including the label, lot number, beyond-use date, and overall appearance of the solution
The most common adverse effects associated with GLP-1 medications are gastrointestinal in nature, including nausea, vomiting, diarrhea, constipation, and abdominal discomfort
The conversion chart for semaglutide dosage in units provides an even more detailed breakdown with every possible dose increment